Taha, Z, Arulanandam, R, Maznyi, G, Godbout, E, Carter-Timofte, M E, Kurmasheva, N, Reinert, L S, Chen, A, Crupi, M J F, Boulton, S, Laroche, G, Phan, A, Rezaei, R, Alluqmani, N, Jirovec, A, Acal, A, Brown, E E F, Singaravelu, R, Petryk, J, Idorn, M, Potts, K G, Todesco, H, John, C, Mahoney, D J, Ilkow, C S, Giguère, P, Alain, T, Côté, M, Paludan, S R, Olagnier, D, Bell, J C, Azad, T & Diallo, J-S 2022, ' Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen ', Molecular Therapy, vol. 30, no. 9, pp. 2998-3016 . https://doi.org/10.1016/j.ymthe.2022.04.025